Expert Discusses Venetoclax Potential in MCL
Pharma & biotech2018-06-22
7 Views
Toby Eyre, MBChB, MRCP, discusses the results of the phase I study with venetoclax in patients with poor-risk relapsed/refractory mantle cell lymphoma.
Source: OncLive
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
BREAKING NEWS: Herbal Works Inc. Continues Social Media Marketing Campaign with Launch of YouTube Channel
